pharmaceutical investing Medexus Announces Fiscal Q3 2026 Results, Driven by Continued Strong Year-To-Date Product-Level Performance of GRAFAPEX for Injection
pharmaceutical investing Medexus Announces US$51.0 million in New Credit Facilities and Intention to Commence Normal Course Issuer Bid, or NCIB, for its Common Shares
pharmaceutical investing Medexus Announces Fiscal Q2 2026 Results, Driven by Strong Year-To-Date Product-Level Performance of GRAFAPEX for Injection
pharmaceutical investing Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors
pharmaceutical investing Medexus Announces Fiscal Q1 2026 Results, Including Positive Results from US Launch of GRAFAPEX for Injection
Cartier Extends Mineralized System 4 km East of Main; Cuts 23.2 g/t Au over 1.0 m at Nordeau ; Expands High-Grade Gold Near Surface at East Nordeau Zone
NevGold Drills 8.51 g/t Oxide AuEq Over 10.6 Meters Within 2.32 g/t Oxide AuEq Over 86.8 Meters ; Discovers High-Grade Oxide Gold-Antimony "Armory Fault" Structure At Bullet Zone
